Kaken Pharmaceutical Co., Ltd. (4521.T) - Quarterly Cash Flow Statement

Home
4521.T
Financials

3893 (JPY) • At close November 5, 2024

Overview | Financials

Numbers are in millions (except for per share data and ratios) JPY.

	2024 Q1	2023 Q4	2023 Q3	2023 Q2	2023 Q1	2022 Q4	2022 Q3	2022 Q2	2022 Q1	2021 Q4	2021 Q3	2021 Q2	2021 Q1	2020 Q4	2020 Q3	2020 Q2	2020 Q1	2019 Q4	2019 Q3	2019 Q2	2019 Q1	2018 Q4	2018 Q3	2018 Q2	2018 Q1	2017 Q4	2017 Q3	2017 Q2	2017 Q1	2016 Q4	2016 Q3	2016 Q2	2016 Q1	2015 Q4	2015 Q3	2015 Q2	2015 Q1	2014 Q4	2014 Q3	2014 Q2	2014 Q1	2013 Q4	2013 Q3	2013 Q2	2013 Q1	2012 Q4	2012 Q3	2012 Q2	2010 Q4	2010 Q3	2010 Q2	2010 Q1	2009 Q4	2009 Q3	2009 Q2	2009 Q1	2008 Q4	2008 Q3
Operating Activities:
Net Income Numbers are in millions	1,754	1,350	2,607	1,558	2,510	-3,709	3,185	3,057	2,907	-697	3,525	3,359	3,362	2,471	3,708	3,406	3,820	3,816	6,007	4,721	4,826	3,528	5,407	4,805	4,035	2,184	5,991	5,405	5,463	4,034	6,537	5,650	5,796	1,009	7,651	6,183	6,300	2,517	3,966	3,009	2,630	2,304	2,833	2,391	2,207	1,611	2,764	2,514	2,005	4,546	3,004	3,990	834	4,266	2,999	2,830	458	3,136
Depreciation & Amortization Numbers are in millions	0	0	671	765	643	672	652	626	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	685	669	603	531	632	616	596	579	653	621
Deferred Income Tax Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Stock Based Compensation Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Change In Working Capital Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3,213	-3,222	357	-323	3,369	-1,798	-236	-513	1,754	-3,297
Accounts Receivables Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Change In Inventory Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	415	-877	182	-1,027	1,350	408	231	-36	-204	-753
Change In Accounts Payables Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Working Capital Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2,798	-2,345	175	704	2,019	-2,206	-467	-477	1,958	-2,544
Other Non Cash Items Numbers are in millions	-1,754	-1,350	-2,607	-1,558	-2,510	3,709	-3,185	-3,057	-2,907	697	-3,525	-3,359	-3,362	-2,471	-3,708	-3,406	-3,820	-3,816	-6,007	-4,721	-4,826	-3,528	-5,407	-4,805	-4,035	-2,184	-5,991	-5,405	-5,463	-4,034	-6,537	-5,650	-5,796	-1,009	-7,651	-6,183	-6,300	-2,517	-3,966	-3,009	-2,630	-2,304	-2,833	-2,391	-2,207	-1,611	-2,764	-2,514	241	-1,230	-258	-1,669	625	-1,518	-388	-1,844	577	-337
Operating Cash Flow Numbers are in millions	0	0	1,342	1,530	1,286	1,344	1,304	1,252	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	6,144	763	3,706	2,529	5,460	1,566	2,971	1,052	3,442	123
Investing Activities:
Investments In Property Plant And Equipment Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-1,613	-906	-2,322	-245	-493	-517	-1,188	-427	-487	-621
Acquisitions Net Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-27	0	0	0	0
Purchases Of Investments Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-688	-312	-1	0	-1	-99	-232	0	-270	0
Sales Maturities Of Investments Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	500	0	0	0	314
Other Investing Activites Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-169	-135	-54	9	-279	-45	349	-59	12	35
Investing Cash Flow Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-2,443	-1,335	-2,322	-202	-757	-134	-1,061	-422	-739	-268
Financing Activities:
Debt Repayment Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Issued Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Repurchased Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Dividends Paid Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-26	-1,624	-281	-1,157	-26	-1,445	-208	-1,066	-20	-1,288
Other Financing Activities Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-16	-145	-4,056	-4	-868	-704	-6	596	199	-1,794
Financing Cash Flow Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-42	-1,769	-4,337	-1,161	-894	-2,149	-214	-470	179	-3,082
Other Information:
Effect Of Forex Changes On Cash Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Net Change In Cash Numbers are in millions	0	0	-3,908	-1,474	-2,726	3,703	-4,910	1,769	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3,660	-2,342	-2,953	1,166	3,810	-718	1,697	159	2,881	-3,227
Cash At End Of Period Numbers are in millions	0	0	66,152	70,060	71,534	74,260	70,557	75,467	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17,035	13,375	15,717	18,670	17,504	13,694	14,412	12,715	12,556	9,675

Kaken Pharmaceutical Co., Ltd.

TSE:4521.T Add to watchlist

TSE:4521.T